Warther Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,773
Closed -$2.96M 70
2022
Q4
$2.96M Sell
5,773
-362
-6% -$184K 2.22% 13
2022
Q3
$2.79M Buy
6,135
+750
+14% +$359K 2.21% 11
2022
Q2
$2.62M Buy
5,385
+3,865
+254% +$1.91M 1.92% 7
2022
Q1
$759K Buy
+1,520
New +$695K 0.49% 59

Other funds holding ELV

Warther Private Wealth's ELV Position: Q1 2023 in Review

Warther Private Wealth sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 5,773 shares — an estimated $2.96M sold.

Warther Private Wealth first reported a position in ELV in Q1 2022 and held it in 4 quarters. The position peaked at $2.96M in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Warther Private Wealth reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Warther Private Wealth sold 5,773 Elevance Health shares in Q1 2023, an estimated $2.96M.
  • Warther Private Wealth first reported a position in Elevance Health in Q1 2022 and held it in 4 quarters.
  • Warther Private Wealth's Elevance Health position peaked at $2.96M in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Warther Private Wealth's 13F filing for Q1 2023, filed 30 May 2023.